Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame | Zendy

James Gaensbauer | Zendy; Chris Gast | Zendy; Ananda S Bandyopadhyay | Zendy; Miguel O’Ryan | Zendy; Xavier SáezLlorens | Zendy; Luis Rivera | Zendy; Eduardo LópezMedina | Zendy; Mario Melgar | Zendy; William C. Weldon | Zendy; M. Steven Oberste | Zendy; Ricardo Rüttimann | Zendy; Ralf Clemens | Zendy; Edwin J. Asturias | Zendy

Open Access

Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame

Author(s) -

James Gaensbauer,

Chris Gast,

Ananda S Bandyopadhyay,

Miguel O’Ryan,

Xavier SáezLlorens,

Luis Rivera,

Eduardo LópezMedina,

Mario Melgar,

William C. Weldon,

M. Steven Oberste,

Ricardo Rüttimann,

Ralf Clemens,

Edwin J. Asturias

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy649

Subject(s) - medicine , poliomyelitis , poliovirus , immunogenicity , polio vaccine , inactivated poliovirus vaccine , antibody , immunology , pediatrics , virus

Quantifying interference of maternal antibodies with immune responses to varying dose schedules of inactivated polio vaccine (IPV) is important for the polio endgame as IPV replaces oral polio vaccine (OPV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research